Improving FDA's COVID-19 vaccine authorization and approval process

(Dartmouth College) On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of COVID-19, and on June 15, the agency revoked this authorization. In JAMA: The Journal of the American Medical Association, a research team proposes reforms that the FDA could implement to improve the EUA process and drug approvals during public health crises, which could increase the FDA's credibility and the public's trust in it.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news